MR编号 | NL/H/5264/001 |
---|
药品名称 | Bortezomib EVER Pharma 2,5 mg/ml solution for injection |
---|
活性成分 | |
---|
剂型 | Solution for injection |
---|
上市许可持有人 | Ever Valinject GmbH
Oberburgau 3
4866 Unterach Am Attersee
Austria |
---|
参考成员国 - 产品名称 | Netherlands (NL) Bortezomib EVER Pharma 2,5 mg/ml oplossing voor injectie |
---|
互认成员国 - 产品名称 | - Hungary (HU)
- Poland (PL)
- Denmark (DK)
- Bulgaria (BG)
Bortezomib EVER Pharma - Belgium (BE)
Bortezomib EVER Pharma 2,5 mg/ml oplossing voor injectie - Czechia (CZ)
Bortezomib Ever Pharma - Ireland (IE)
- France (FR)
- Romania (RO)
Bortezomib EVER Pharma 2,5 mg/ml Solution for injection - Spain (ES)
- Slovakia (SK)
- Portugal (PT)
- Croatia (HR)
- Italy (IT)
- Slovenia (SI)
- Sweden (SE)
- Norway (NO)
Bortezomib EVER Pharma - Finland (FI)
|
---|
许可日期 | 2021/09/14 |
---|
最近更新日期 | 2024/11/14 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|